NCT05977842已完成不适用
Drug-coated Balloon in de Novo Chronic Total Occlusions (CTO-DENOVO Registry)
National Institute of Cardiology, Warsaw, Poland33 个研究点 分布在 12 个国家目标入组 309 人开始时间: 2012年12月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 309
- 试验地点
- 33
- 主要终点
- Target lesion failure
研究概览
简要总结
The CTO-DENOVO study is a multicenter registry of consecutive patients with de novo coronary chronic total occlusions (CTO) undergoing successful CTO recanalization with the use of drug-coated balloon (DCB)-only strategy. The primary endpoint is target lesion failure at 6 months. The secondary endpoints are: 1) late lumen loss on follow-up angiography, and 2) minimal lumen area on follow-up intravascular ultrasound.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •de novo coronary CTO undergoing successful recanalization with the use of DCB-only strategy at the occlusion site
排除标准
- •de novo coronary CTO undergoing successful recanalization with the use of DES at the occlusion site
- •in-stent CTO
结局指标
主要结局
Target lesion failure
时间窗: 6 months
Composite of cardiac death, target vessel-related myocardial infarction, or clinically-driven target lesion revascularization
次要结局
- Late lumen loss(3 months)
- Minimal lumen area(3 months)
研究者
研究点 (33)
Loading locations...
相似试验
招募中
不适用
DCB Treatment in CTO Guided by IVUSCoronary Artery DiseaseNCT06050096Xuzhou Central Hospital100
招募中
不适用
Impact of Drug-coated Balloon Treatment in de Novo Coronary LesionDrug-coated BalloonNCT04619277Ulsan Medical Center10,000
已完成
不适用
DCB Angioplasty for Coronary Lesions: an OCT AnalysisCoronary StenosisDrug-coated BalloonNCT04984135The First Affiliated Hospital of Dalian Medical University70
招募中
不适用
Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary InterventionTotal Occlusion of Coronary ArteryCoronary Artery DiseaseNCT06275386National Institute of Cardiology, Warsaw, Poland30
Unknown
不适用
DISsection RE-entry Evaluation With Absorb Bioresorbable Vascular Scaffolds in CTO.Coronary Artery DiseaseNCT02936011Belfast Health and Social Care Trust50